SecSonar.com

Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Perspective Therapeutics, Inc. (CATX) is a Medical - Devices company based in US with a market capitalization of $310.2M. Free cash flow was negative at -$95.2M. This page tracks CATX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 138 employees · IPO Nov 10, 2005

Valuation

Valuation & price

$3.85 · as of May 17, 2026 · -31.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.50

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.65$3.85$2.05Jul 25Dec 25Jul 26Jul 7, 25$3.48Jul 9, 25$3.78Jul 11, 25$3.98Jul 15, 25$3.90Jul 17, 25$4.13Jul 21, 25$4.31Jul 23, 25$4.35Jul 25, 25$4.06Jul 29, 25$3.92Jul 31, 25$3.84Aug 4, 25$3.89Aug 6, 25$3.82Aug 11, 25$3.72Aug 13, 25$3.81Aug 15, 25$3.61Aug 19, 25$3.42Aug 21, 25$3.56Aug 25, 25$3.46Aug 27, 25$3.61Aug 29, 25$3.36Sep 3, 25$3.38Sep 5, 25$3.46Sep 9, 25$3.37Sep 11, 25$3.38Sep 16, 25$3.27Sep 18, 25$3.29Sep 22, 25$3.30Sep 24, 25$3.26Sep 26, 25$3.40Sep 30, 25$3.43Oct 2, 25$3.49Oct 6, 25$3.55Oct 8, 25$3.86Oct 10, 25$4.86Oct 14, 25$4.84Oct 16, 25$4.75Oct 21, 25$3.11Oct 23, 25$2.88Oct 27, 25$3.10Oct 29, 25$2.73Oct 31, 25$2.73Nov 4, 25$2.33Nov 6, 25$2.23Nov 10, 25$2.22Nov 12, 25$2.12Nov 14, 25$2.08Nov 18, 25$2.28Nov 20, 25$2.12Nov 25, 25$2.19Nov 28, 25$2.35Dec 2, 25$2.05Dec 4, 25$2.39Dec 8, 25$2.40Dec 10, 25$2.55Dec 12, 25$2.67Dec 16, 25$2.84Dec 18, 25$2.67Dec 22, 25$2.85Dec 24, 25$2.81Dec 29, 25$2.73Jan 2, 26$2.79Jan 6, 26$2.81Jan 8, 26$2.81Jan 12, 26$2.41Jan 14, 26$2.62Jan 16, 26$2.33Jan 21, 26$2.55Jan 23, 26$2.71Jan 27, 26$2.70Jan 29, 26$4.26Feb 2, 26$5.06Feb 4, 26$5.10Feb 9, 26$4.84Feb 11, 26$4.88Feb 13, 26$4.70Feb 18, 26$5.03Feb 20, 26$5.65Feb 24, 26$5.42Feb 26, 26$5.06Mar 2, 26$5.35Mar 4, 26$5.27Mar 6, 26$4.97Mar 10, 26$5.35Mar 12, 26$5.11Mar 17, 26$4.95Mar 19, 26$4.60Mar 23, 26$4.24Mar 25, 26$4.52Mar 27, 26$4.07Mar 31, 26$4.17Apr 2, 26$4.41Apr 7, 26$4.37Apr 9, 26$4.49Apr 13, 26$4.35Apr 15, 26$4.38Apr 17, 26$4.20Apr 22, 26$4.71Apr 24, 26$4.51Apr 28, 26$3.95Apr 30, 26$3.90May 4, 26$3.98May 6, 26$3.82May 8, 26$3.76May 12, 26$3.77May 14, 26$3.86May 18, 26$3.76May 20, 26$3.77May 22, 26$3.98May 28, 26$4.05Jun 1, 26$3.66Jun 3, 26$3.56Jun 5, 26$3.03Jun 9, 26$3.00Jun 11, 26$2.97Jun 15, 26$2.94Jun 17, 26$2.98Jun 22, 26$3.05Jun 24, 26$3.00Jun 26, 26$3.04Jul 2, 26$3.63
$2.0552-week range$5.65
Loading valuation history…

Fundamentals

Key fundamentals

$310.2M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$95.2M

Free cash flow (USD)

-$143.1M

Net debt

Net cash position

14.6%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$4.8MFY 2018$5.9MFY 2019$7.3MFY 2020$9.7MFY 2021$10.1MFY 2022$10.8MFY 2023$1.4MFY 2024$0.00FY 2025$0.00
$4.8M$0

Free cash flow by year

2017 → 2025

FY 2017$-6.3MFY 2018$-6.0MFY 2019$-5.5MFY 2020$-3.9MFY 2021$-3.2MFY 2022$-8.0MFY 2023$-38.0MFY 2024$-72.7MFY 2025$-95.2M
-$6.3M-$95.2M

Gross margin by year

2021 → 2023

FY 202150.9%FY 202242.8%FY 2023100.0%
50.9%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCorporate Presentation UpdateJul 1, 2026Filing
  • 8-K eventCorporate Presentation UpdateJun 1, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 27, 2026Filing
  • 8-K eventClinical Data PresentationMay 22, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing
  • 8-K eventEarnings ReleaseMay 4, 2026Filing
  • 8-K eventClinical Trial UpdateApr 20, 2026Filing
  • 8-K eventCorporate Presentation UpdateApr 1, 2026Filing

Questions

Frequently asked questions

What is Perspective Therapeutics, Inc.'s market cap?

Perspective Therapeutics, Inc. (CATX) has a market capitalization of $310.2M.

What is CATX's P/E ratio?

A meaningful P/E ratio is not available for CATX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CATX's price-to-book (P/B) ratio?

CATX trades at 1.50 times book value per share.

Are insiders buying CATX stock?

SEC Form 4 filings show no open-market insider buys at Perspective Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

AVR

Anteris Technologies Global Corp.

$314.1M

ELMD

Electromed, Inc.

$318.5M

MASS

908 Devices Inc.

$322.7M

SENS

Senseonics Holdings, Inc.

$280.3M

SGHT

Sight Sciences, Inc.

$270.1M

DCTH

Delcath Systems, Inc.

$368.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.